# Clinical trials recruiting in North Carolina: 2,820 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 2,820 trials recruiting or not yet recruiting with a site in North Carolina, as read on November 19, 2026.

## The full list

Clinical trials recruiting in North Carolina: 2,820 rows for $108.20, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 48 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/north-carolina

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 2,820
- Recruiting or not yet: 2,820
- Read on: November 19, 2026

## Trials

The 25 newest of 2,820, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 18, 2026 | NCT07945041 | Optimizing Acute Care Rehabilitation for Critically Ill Adults | University of Colorado, Denver | Not applicable | Not yet recruiting | ICU Acquired Muscle Weakness, Critical Illness, Functional Impairment, Rehabilitation After Critical Illness | 360 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07945041) |
| November 18, 2026 | NCT07944326 | Cardiovascular and Renal Protection With SGLT Inhibition in Kidney Transplant Recipients: The RENAISSANCE Trial | University of British Columbia | Phase 3 | Not yet recruiting | Kidney Transplant Recipient | 900 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07944326) |
| November 17, 2026 | NCT07943754 | Fighting Osteoporosis With Risedronate Co-Therapy During Incretin | Wake Forest University Health Sciences | Phase 3 | Not yet recruiting | Obesity | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07943754) |
| November 16, 2026 | NCT07940400 | Integrated Clinical Evaluation of Biomarkers, Radiogenomics, and Genomics in Prostate Cancer | Wake Forest University Health Sciences | Observational | Not yet recruiting | Prostate Cancer | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940400) |
| November 16, 2026 | NCT07939529 | People With Active Viremia Treated With Lenacapavir and Long-Acting Cabotegravir for Effectiveness | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 | Not yet recruiting | HIV Viremia | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939529) |
| November 16, 2026 | NCT07938840 | Opioid-Free Total Shoulder With Suzetrigine | OrthoCarolina Research Institute, Inc. | Phase 4 | Not yet recruiting | Osteo Arthritis Shoulders, Avascular Necrosis of Bone | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07938840) |
| November 16, 2026 | NCT07937943 | Pharmacokinetic (PK) Study of Phytochemicals in Whole Grains (WGs)- Barley | North Carolina Agriculture & Technical State University | Not applicable | Recruiting | Healthy Adult Females, Healthy Adult Males | 16 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07937943) |
| November 13, 2026 | NCT07935356 | A Phase 3 Evaluation of Sutacimig in Glanzmann Thrombasthenia | Sponsor not shown (see the record) | Phase 3 | Recruiting | Thrombasthenia | 76 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935356) |
| November 12, 2026 | NCT07934186 | LM11A-31 Safety and Tolerability in Aging People Living With HIV and Neurocognitive Impairment | University of North Carolina, Chapel Hill | Phase 1/2 | Not yet recruiting | HIV-ASSOCIATED NEUROCOGNITIVE DISORDER (HAND) | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934186) |
| November 12, 2026 | NCT07931703 | Safety, Tolerability and Efficacy of RGH-202 in Social Anxiety Disorder (STAGE) | Gedeon Richter Plc. | Phase 2 | Not yet recruiting | Social Anxiety Disorder | 156 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931703) |
| November 12, 2026 | NCT07931690 | IMPACT-Ready Study | Sponsor not shown (see the record) | Observational | Not yet recruiting | Autism Spectrum Disorder, Neurodevelopmental Disorders | 1,250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931690) |
| November 12, 2026 | NCT07931599 | A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 1,060 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931599) |
| November 12, 2026 | NCT07931573 | AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes | 1,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931573) |
| November 12, 2026 | NCT07931547 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931547) |
| November 12, 2026 | NCT07931495 | A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Diabetes Mellitus, Type 2 | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07931495) |
| November 10, 2026 | NCT07927244 | Improving Rural Endometrial Cancer Care | UNC Lineberger Comprehensive Cancer Center | Not applicable | Recruiting | Endometrial Cancer | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07927244) |
| November 9, 2026 | NCT07926321 | A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment | Boehringer Ingelheim | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926321) |
| November 9, 2026 | NCT07925710 | Osteoarthritis Care Tools for Primary Care Providers in Family Medicine and Geriatrics Clinics | University of North Carolina, Chapel Hill | Not applicable | Not yet recruiting | Arthritis, Osteo Arthritis Knee and Hip | 205 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07925710) |
| November 6, 2026 | NCT07923591 | Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923591) |
| November 6, 2026 | NCT07923526 | An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic... | United Therapeutics | Phase 2/3 | Not yet recruiting | Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07923526) |
| November 6, 2026 | NCT07922785 | Stair Biomechanics and Vibration Study After ACLR | University of North Carolina, Chapel Hill | Not applicable | Not yet recruiting | Anterior Cruciate Ligament Reconstruction (ACLR), Anterior Cruciate Ligament Injury | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922785) |
| November 6, 2026 | NCT07922772 | Days-Off Versus Daily Initial Peritoneal Dialysis Prescription | University of Michigan | Not applicable | Not yet recruiting | Kidney Failure | 450 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07922772) |
| November 5, 2026 | NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) | Pfizer | Phase 3 | Recruiting | Obesity, Overweight, Osteoarthritis of the Knee | 656 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919678) |
| November 5, 2026 | NCT07919405 | A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Hypertension, Obesity | 1,408 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07919405) |
| November 5, 2026 | NCT07917845 | Evaluation of Massage Therapy for Cancer Related Fatigue in Breast Cancer Survivors | Wake Forest University Health Sciences | Not applicable | Not yet recruiting | Breast Cancer, Fatigue in Cancer Survivors | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07917845) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Duke University Medical Center | Durham | 308 |
| Duke University | Durham | 196 |
| Wake Forest University Health Sciences | Winston-Salem | 153 |
| University of North Carolina at Chapel Hill | Chapel Hill | 146 |
| University of North Carolina | Chapel Hill | 97 |
| UNC Lineberger Comprehensive Cancer Center | Chapel Hill | 96 |
| East Carolina University | Greenville | 82 |
| Levine Cancer Institute | Charlotte | 60 |
| Carolinas Medical Center/Levine Cancer Institute | Charlotte | 58 |
| Duke University Hospital | Durham | 57 |
| Atrium Health Wake Forest Baptist | Winston-Salem | 50 |
| Duke University Health System | Durham | 47 |
| Duke Cancer Institute | Durham | 46 |
| Duke Cancer Center | Durham | 36 |
| Durham VA Medical Center, Durham, NC | Durham | 35 |
| Southeastern Medical Oncology Center-Clinton | Clinton | 33 |
| Southeastern Medical Oncology Center-Goldsboro | Goldsboro | 33 |
| Southeastern Medical Oncology Center-Jacksonville | Jacksonville | 33 |
| Atrium Health | Charlotte | 30 |
| Novant Health Presbyterian Medical Center | Charlotte | 30 |
| Mission Hospital | Asheville | 28 |
| Wake Forest University | Winston-Salem | 27 |
| Atrium Health Cabarrus/LCI-Concord | Concord | 25 |
| FirstHealth of the Carolinas-Moore Regional Hospital | Pinehurst | 24 |
| Duke Cancer Center Raleigh | Raleigh | 24 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 9 |
| Phase 1 | 198 |
| Phase 1/2 | 166 |
| Phase 2 | 503 |
| Phase 2/3 | 71 |
| Phase 3 | 650 |
| Phase 4 | 108 |
| Not applicable | 663 |
| Observational | 452 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Neoplasms | 105 |
| Breast Neoplasms | 104 |
| Carcinoma, Non-Small-Cell Lung | 94 |
| Obesity | 72 |
| Neoplasm Metastasis | 63 |
| Multiple Myeloma | 57 |
| Lung Neoplasms | 55 |
| Colorectal Neoplasms | 54 |
| Leukemia, Myeloid, Acute | 50 |
| Recurrence | 49 |
| Prostatic Neoplasms | 49 |
| Heart Failure | 45 |
| Ovarian Neoplasms | 44 |
| Diabetes Mellitus, Type 2 | 43 |
| Pancreatic Neoplasms | 43 |
| Overweight | 43 |
| Endometrial Neoplasms | 40 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 36 |
| Squamous Cell Carcinoma of Head and Neck | 33 |
| Cardiovascular Diseases | 33 |
| Melanoma | 33 |
| Motor Activity | 30 |
| Pulmonary Disease, Chronic Obstructive | 29 |
| Stroke | 29 |
| Depression | 29 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Duke University | 210 |
| Wake Forest University Health Sciences | 171 |
| University of North Carolina, Chapel Hill | 102 |
| UNC Lineberger Comprehensive Cancer Center | 88 |
| National Cancer Institute (NCI) | 70 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 64 |
| [AbbVie](https://specstream.ai/data/clinical-trials/company/abbvie) | 41 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 40 |
| VA Office of Research and Development | 39 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 39 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 35 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 31 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 29 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 28 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 26 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 25 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 23 |
| Alliance for Clinical Trials in Oncology | 22 |
| Children's Oncology Group | 22 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 21 |
| SWOG Cancer Research Network | 20 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 19 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 19 |
| [Amgen](https://specstream.ai/data/clinical-trials/company/amgen) | 18 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 18 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in North Carolina

- [Nephrology practices in North Carolina, United States](https://specstream.ai/data/businesses/nephrology-practices/north-carolina-united-states)
- [Well drilling companies in North Carolina, United States](https://specstream.ai/data/businesses/well-drilling-companies/north-carolina-united-states)
- [Electronic parts suppliers in North Carolina, United States](https://specstream.ai/data/businesses/electronic-parts-suppliers/north-carolina-united-states)
- [Oncology practices in North Carolina, United States](https://specstream.ai/data/businesses/oncology-practices/north-carolina-united-states)
- [Wineries in North Carolina, United States](https://specstream.ai/data/businesses/wineries/north-carolina-united-states)
- [Energy companies in North Carolina, United States](https://specstream.ai/data/businesses/energy-companies/north-carolina-united-states)
